7Baggers
Quarterly
Annual
    Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2016-12-31 2015-06-30 2015-03-31 2014-09-30 2013-12-31 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 
      
    		                                             
      cash flows from operating activities:
    		                                             
      net income
    		-1,661,000 -79,201,000 539,000 -184,937,000 5,056,000 -23,132,000 -42,761,000 -37,841,000 -8,663,000 -24,268,000 -14,708,000 -5,310,000 11,438,000 -8,369,000 14,935,000 7,694,000 2,323,000 -5,471,000 -7,190,000 3,417,000 -2,964,000 613,000 -18,268,000 -512,000 2,511,000 -5,991,000 8,002,000  -1,320,000  2,536,000 2,511,000 3,768,000 695,000 541,000 -158,000 551,000 -668,000 740,000 1,829,000 1,925,000 2,447,000 1,404,000 867,000 625,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                             
      depreciation and amortization
    		35,530,000 45,733,000 33,892,000 29,246,000 34,311,000 33,806,000 32,941,000 33,340,000 33,408,000 32,182,000 31,618,000 29,515,000 29,850,000 30,010,000 28,392,000 28,584,000 28,951,000 28,443,000 27,683,000 28,104,000 26,735,000 26,915,000 19,517,000 19,332,000 19,563,000 19,185,000 19,546,000  15,492,000  5,725,000 5,333,000 4,253,000 4,663,000 3,118,000 3,384,000 3,393,000 3,224,000 2,399,000 1,700,000 1,550,000 1,578,000 1,548,000 1,493,000 1,451,000 
      non-cash compensation expense
    		16,484,000 17,822,000 18,898,000 12,890,000 17,298,000 21,390,000 19,453,000 17,750,000 17,265,000 23,504,000 21,814,000 17,713,000 18,885,000 17,285,000 14,137,000 13,916,000 15,852,000 13,884,000 15,985,000 17,277,000                          
      non-cash interest expense
    		1,420,000 -1,763,000 4,580,000 -1,785,000 4,571,000 -2,247,000 4,498,000 2,009,000 1,962,000 875,000 2,599,000 910,000 1,983,000 891,000 2,015,000 6,260,000 6,348,000 1,444,000 4,463,000 2,051,000 7,299,000 3,016,000 6,880,000 2,197,000 6,707,000 2,421,000 3,209,000  3,858,000                 
      non-cash goodwill impairment
    		0                                             
      non-cash gain on deconsolidation
    		0                                             
      non-cash convertible promissory note impairment
    		                                             
      income from equity method investments
    		1,526,000                                             
      fair market value adjustments to investments in private companies
    		                                             
      lease related impairments
    		   2,637,000 0                                         
      other
    		-3,293,000 42,000 2,078,000 626,000 851,000 407,000 -103,000 36,000 152,000 226,000 -59,000 216,000 -33,000 117,000 165,000 -1,285,000 0   2,600,000 -1,200,000 -1,000,000 -1,000,000                       
      changes in operating assets and liabilities:
    		                                             
      fees receivable
    		19,391,000 6,028,000 -18,841,000 -10,963,000 12,736,000 -778,000 -21,579,000 -6,577,000 -12,148,000 5,033,000 8,661,000 21,299,000 -36,696,000 -1,807,000 473,000 -4,230,000 -2,265,000 5,773,000 -14,333,000 -5,025,000 6,700,000 -1,734,000 1,198,000  -927,000 1,987,000 -10,191,000        -1,683,000 1,504,000 -2,061,000 540,000 1,034,000 1,396,000 102,000 -125,000 567,000 -1,373,000  
      prepaid expenses and other assets
    		-2,199,000 -3,374,000 -2,371,000 5,961,000 -10,772,000 3,096,000 -9,858,000                                       
      accounts payable, accrued expenses and other liabilities
    		28,267,000 26,610,000 -40,659,000 21,077,000 -19,548,000 50,617,000 -32,917,000                                       
      deferred revenue
    		-6,007,000 94,000 2,400,000 4,703,000 -3,122,000 -8,925,000 8,073,000 2,024,000 -6,606,000 -6,820,000 11,097,000 -1,015,000 -3,854,000 -5,093,000 7,882,000 -5,613,000 -5,748,000 1,638,000 5,598,000 -504,000 -2,709,000 -3,099,000 7,039,000 -802,000 -2,331,000 -3,578,000 7,056,000  -1,078,000  1,890,000 4,088,000 645,000 871,000 461,000 428,000 126,000 23,000 451,000 -388,000 11,000 34,000 -164,000 151,000  
      net cash from operating activities
    		95,355,000 89,110,000 1,944,000 75,591,000 40,009,000 72,789,000 -33,521,000 30,802,000 33,593,000 49,381,000 3,261,000 80,603,000 50,815,000 69,350,000 49,809,000 38,157,000 66,656,000 56,035,000 8,988,000 46,881,000 59,454,000 14,966,000 -12,575,000 34,071,000 42,360,000 41,707,000 -753,000 37,004,000 36,059,000 24,935,000   16,932,000 14,272,000 3,755,000 9,452,000 9,223,000 4,936,000 4,930,000 5,913,000 6,163,000 7,637,000 5,008,000 5,448,000 1,867,000 
      capex
    		-19,143,000 -22,070,000 -20,504,000 -23,910,000 -26,955,000 -35,459,000 -26,048,000 -24,456,000 -28,683,000 -26,619,000 -25,567,000 -24,098,000 -21,644,000 -21,039,000 -22,120,000 -17,915,000 -19,049,000 -16,300,000 -13,732,000 -14,196,000 -15,349,000 -8,398,000 -12,432,000 -9,893,000 -14,508,000 -10,604,000 -9,587,000 0 -5,810,000 0   0 0 -1,370,000 -1,392,000 -1,809,000 -3,028,000 -959,000 -888,000 -1,658,000 -1,880,000 -1,854,000 -1,169,000 -986,000 
      free cash flows
    		76,212,000 67,040,000 -18,560,000 51,681,000 13,054,000 37,330,000 -59,569,000 6,346,000 4,910,000 22,762,000 -22,306,000 56,505,000 29,171,000 48,311,000 27,689,000 20,242,000 47,607,000 39,735,000 -4,744,000 32,685,000 44,105,000 6,568,000 -25,007,000 24,178,000 27,852,000 31,103,000 -10,340,000 37,004,000 30,249,000 24,935,000   16,932,000 14,272,000 2,385,000 8,060,000 7,414,000 1,908,000 3,971,000 5,025,000 4,505,000 5,757,000 3,154,000 4,279,000 881,000 
      cash flows from investing activities:
    		                                             
      purchases of property and equipment
    		-767,000 -3,272,000 -1,900,000 -720,000 -1,540,000 -12,333,000 -4,402,000 -3,058,000 -3,973,000 -5,245,000 -3,896,000 -7,952,000 -4,422,000 -4,295,000 -7,062,000 -3,264,000 -4,495,000 -2,169,000 -2,160,000 -3,749,000 -7,283,000                         
      capitalization of internally developed software
    		-18,376,000 -18,798,000 -19,953,000 -23,190,000 -24,316,000 -23,137,000 -23,664,000 -21,398,000 -24,710,000 -21,374,000 -21,671,000 -16,146,000 -17,222,000 -16,744,000 -15,058,000 -14,651,000 -14,554,000 -14,131,000 -11,572,000 -10,447,000 -8,066,000 -8,398,000 -7,185,000 -6,457,000 -6,989,000 -6,023,000 -4,599,000  -3,559,000      -765,000 -652,000 -710,000 -642,000 -346,000 -347,000 -318,000 -382,000 -435,000 -378,000 -322,000 
      deconsolidation of non-controlling interest
    		0                                             
      investments in private companies
    		0 -250,000 -2,805,000 0 -2,725,000 -500,000 -950,000 0 -8,351,000 -5,000,000 -3,000,000 -17,000,000 -4,377,000 -2,011,000 -2,538,000 -1,765,000 -1,250,000 -925,000 -11,700,000                           
      acquisition of proprietary technology
    		-1,481,000   -5,000,000 0 -2,000,000 -10,000,000 0 0 0 -15,000,000 0 0 0 -25,517,000                               
      issuance of loan receivable to private company
    		   0 0 0 -20,000,000                                       
      net cash from investing activities
    		-20,624,000 -36,393,000 -24,658,000 -28,896,000 -28,500,000 -37,911,000 -58,756,000 -24,371,000 -128,747,000 -51,941,000 -46,067,000 -41,098,000 -25,672,000 -59,193,000 -50,175,000 -16,783,000 -20,299,000 -17,225,000 -45,689,000 -11,190,000 -16,549,000 -323,476,000 -24,493,000 -12,021,000 -21,122,000 -20,366,000 -188,170,000 -6,927,000 -7,260,000 -20,239,000     -1,370,000 -2,278,000 -1,808,000 -65,548,000 -73,000 -24,602,000 -1,652,000 -2,040,000 -1,839,000   
      cash flows from financing activities:
    		                                             
      proceeds from borrowings on revolving credit facility
    		    15,000,000           0 0 0 45,000,000 170,000,000 0   0 0 0 195,000,000  10,000,000                 
      payments related to revolving credit facility
    		   0 -35,000,000                                         
      payments related to convertible notes
    		    0                                         
      proceeds from exercise of stock options
    		357,000 653,000 71,000 769,000 367,000 105,000 367,000 61,000 1,817,000 84,000 658,000 1,170,000 347,000 51,000 522,000 2,707,000 1,370,000 3,275,000 3,408,000 3,563,000 2,115,000 1,751,000 3,163,000 106,000 2,659,000 136,000 2,404,000  1,851,000  2,199,000 3,710,000 1,531,000 822,000 56,000 142,000 362,000 617,000 948,000 45,000 442,000 1,188,000 1,072,000 582,000 93,000 
      payments related to tax withholdings for stock-based compensation
    		-3,692,000 -3,706,000 -8,449,000 -2,018,000 -3,230,000 -3,042,000 -10,732,000                                       
      payments related to share repurchases
    		   0 0 0 -9,289,000                                       
      proceeds from capital contributions received by non-controlling interest
    		0 0 12,012,000                                           
      purchase of non-controlling units from third-party shareholders
    		   0 0 0 -1,008,000                                       
      net cash from financing activities
    		-3,334,000 -3,053,000 3,637,000 4,263,000 -27,581,000 -28,576,000 -20,812,000 -82,552,000 -709,000 -17,509,000 -26,232,000 -4,014,000 -848,000 -12,138,000 -12,170,000 96,000 223,984,000 -15,341,000 24,211,000 -24,597,000 -48,722,000 140,438,000 -6,654,000 113,318,000 -1,323,000 67,189,000 173,110,000 -18,871,000 -7,712,000 -2,766,000 6,112,000 8,739,000 27,110,000 1,661,000 -150,000 1,676,000 318,000 3,376,000 870,000 45,000 442,000 1,188,000 978,000 -180,000 39,617,000 
      effect of exchange rate on changes on cash and cash equivalents
    		-8,000 4,000 -2,000                                           
      net change in cash and cash equivalents
    		71,389,000 60,741,000 -30,152,000                                           
      cash and cash equivalents, beginning of period
    		0 0 91,378,000                          0  0 209,754,000 0 0 29,983,000 0 0 0 64,909,000 0 0 0 67,668,000 0 0 
      cash and cash equivalents, end of period
    		71,389,000 60,741,000 61,226,000                         11,411,000 20,974,000 1,930,000 -10,987,000 209,914,000 41,435,000 13,259,000 32,218,000 8,850,000 7,733,000 -57,236,000 70,636,000 -18,644,000 4,953,000 6,785,000 71,815,000 4,103,000 40,735,000 
      supplemental disclosures of cash flow information
    		                                             
      net cash paid for income taxes
    		7,077,000 5,530,000 568,000 2,314,000 10,329,000 2,113,000 1,110,000                                       
      cash paid for interest
    		3,117,000 7,861,000 1,509,000 7,870,000 1,631,000 8,778,000 1,822,000                                       
      supplemental disclosure of non-cash activities
    		                                             
      conversion of equity method investee loan to shares
    		   0 0 0 4,129,000 0 0                                     
      right-of-use assets obtained in exchange for lease liabilities
    		   1,036,000 -21,000 174,000 206,000                                       
      purchases of property and equipment included in accounts payable, accrued expenses and other liabilities
    		                                             
      purchase of property and equipment included in accounts payable, accrued expenses and other liabilities
    		  1,349,000  -1,099,000 11,000 2,018,000                                       
      deferred income taxes
    		  -855,000 -21,000 -936,000 -5,743,000 5,221,000 890,000 3,842,000 10,733,000 -18,955,000 -7,398,000 -1,059,000 11,718,000 -3,581,000 -1,963,000 1,677,000 -11,000 -1,587,000 -2,004,000 -8,635,000 -29,160,000 169,000 -1,775,000 -4,761,000 830,000 -17,923,000  122,000  -1,080,000 1,888,000   -570,000 645,000 -130,000 -444,000 12,000 -632,000 677,000 1,342,000 775,000 506,000 551,000 
      loss allocations from equity method investments
    		  2,283,000 2,339,000 2,368,000 2,932,000 2,940,000 3,542,000 2,387,000 1,400,000 1,545,000                                   
      net change in cash and cash equivalents due to cash reclassified to assets held for deconsolidation
    		  -11,073,000                                           
      goodwill impairment
    		                                             
      fair market value adjustment to investment in private company
    		   2,000,000        0 0                                 
      dilution gain on equity method investee share issuance
    		   0 0    0                                     
      loss on extinguishment of convertible notes due 2023
    		                                             
      gain on extinguishment of convertible notes due 2025
    		                                             
      loss on property and equipment disposals
    		                                             
      payments of contingent consideration
    		           0 0 -1,360,000 -1,000,000     0 0        0                 
      fair market value adjustment to contingent consideration liability
    		           0 -927,000 0 -140,000 -1,049,000 -74,000                             
      gain on settlement of liability
    		           0                                  
      acquisitions of businesses, net of cash acquired
    		       85,000 -89,713,000   0 349,000   0 0 0 -20,257,000 656,000 0                         
      issuance of note receivable to equity method investees
    		                                             
      proceeds from borrowings under revolving credit facility
    		                                             
      settlement of convertible notes due 2023
    		                                             
      proceeds from issuance of convertible notes due 2027
    		                                             
      convertible notes due 2027 issuance costs
    		                                             
      repurchase of convertible notes due 2023
    		                                             
      repurchase of convertible notes due 2025
    		                                             
      payments related to capped call transactions
    		                                             
      proceeds from capital contributions of non-controlling shareholders
    		                                             
      effect of exchange rate on changes on cash, cash equivalents and restricted cash
    		   -2,791,000 264,000 53,000 3,580,000                                       
      net change in cash, cash equivalents and restricted cash
    		   48,167,000 -15,808,000 6,355,000 -109,509,000                                       
      cash, cash equivalents and restricted cash, beginning of period
    		   0 0 0 162,173,000 0 0 0 429,428,000 0 0 0 384,714,000 0 0 0 82,755,000 0 0 0 289,671,000   0 62,115,000                   
      cash, cash equivalents and restricted cash, end of period
    		   48,167,000 -15,808,000 6,355,000 52,664,000 -79,157,000 -96,934,000 -21,499,000 359,763,000 35,480,000 24,275,000 -2,453,000 372,126,000 21,648,000 270,674,000 23,623,000 68,769,000 10,873,000 -6,161,000 -168,018,000 246,061,000   88,067,000 46,193,000                   
      supplemental disclosure of cash flow information
    		                                             
      purchase of fixed assets included in accounts payable and accrued expenses and other current liabilities
    		                                             
      treasury stock purchases included in accrued expenses and other liabilities
    		                                             
      membership interest liabilities included in other liabilities
    		                                             
      common stock issued to settle purchase liability
    		                   0 0 0 772,000                       
      internally developed software costs included in accrued expenses and other liabilities
    		         450,000 178,000 -469,000                                  
      leasehold improvements funded by lease incentive
    		           0 0 37,000 127,000 40,000   894,000   159,000 489,000      1,817,000       0    0    0 0 
      purchase liabilities included in accrued expenses and other liabilities
    		               0   375,000       -11,750,000 13,172,000  19,000                 
      release of uncertain tax positions
    		        0                                     
      loss on property and equipment disposals - office closures
    		        0                                     
      payments on finance lease obligations
    		    -4,719,000 -640,000 -152,000                                       
      property and equipment acquired through finance lease
    		    4,719,000 640,000 152,000                                       
      internally developed software costs included in accounts payable, accrued expenses and other liabilities
    		                                             
      benefit from doubtful accounts
    		      571,000 979,000 762,000 517,000 -1,747,000 -453,000 1,596,000 157,000 298,000 494,000 808,000 489,000 1,026,000 1,612,000 530,000 262,000 451,000 390,000 304,000 463,000 461,000  487,000     50,000 60,000         0 0 
      membership interest liabilities included in other non-current liabilities
    		       0 0 628,000 124,000 123,000 125,000 124,000 124,000 124,000   2,220,000 2,220,000 2,220,000                         
      operating activities:
    		                                             
      accretion on contingent consideration and purchase liability
    		           74,000 81,000 187,000 388,000 380,000 398,000 311,000 599,000 532,000 498,000 502,000 240,000 13,000 13,000 95,000 101,000  104,000                 
      gain on equity method investments
    		                                             
      lease related impairments, including right-of-use assets
    		                                             
      changes in operating assets and liabilities, net of acquisitions:
    		                                             
      prepaid expenses and other current assets
    		       11,474,000 -5,889,000 5,656,000 -8,377,000 -170,000 724,000 -1,911,000 1,756,000 1,473,000 -3,383,000 -963,000 -6,793,000 -1,656,000 10,723,000 -2,161,000 -13,346,000 3,852,000 -1,313,000 239,000 -3,665,000  -2,635,000    1,511,000  -169,000 1,561,000 4,100,000 -1,919,000 903,000 -1,116,000 -450,000 58,000 -480,000 571,000  
      other non-current assets
    		       -1,078,000 -276,000 -2,524,000 -1,114,000 -2,113,000 1,189,000 572,000 3,093,000 -156,000 -1,454,000 -994,000 641,000 879,000 -2,872,000 -2,181,000 -1,060,000 -448,000 -438,000 11,000 -2,461,000  -1,270,000      -241,000 6,000 -261,000   71,000    -134,000  
      accrued expenses and other liabilities
    		       -1,543,000 8,794,000 -4,642,000 -27,320,000 26,628,000 26,110,000 29,195,000 -28,668,000 18,716,000 7,877,000 7,070,000 -11,554,000 8,921,000 9,328,000 15,435,000 -34,495,000 6,229,000 12,158,000 11,956,000 -17,404,000  14,041,000                 
      accounts payable
    		       -2,857,000 -2,235,000 1,800,000 -432,000 -2,832,000 1,789,000 -4,111,000 6,444,000 -12,271,000 14,214,000 1,075,000 -3,205,000 3,996,000 -2,091,000 -9,947,000 5,179,000 -2,357,000 -66,000 2,572,000 1,594,000  1,619,000  1,251,000 188,000 809,000 1,023,000 -122,000 95,000 -164,000 417,000 292,000 -39,000 255,000 -298,000 349,000 -53,000  
      other non-current liabilities
    		       6,723,000 -251,000 -933,000 -1,361,000 1,999,000 -990,000 1,760,000 -1,068,000 -8,046,000 138,000 2,091,000 -145,000 1,553,000 640,000 1,748,000 854,000 568,000 693,000 206,000 1,372,000  -1,170,000    134,000 114,000 -66,000 987,000 63,000 71,000 45,000 -243,000 72,000 72,000 60,000 36,000  
      investing activities:
    		                                             
      advance for technology solutions
    		       0 0   0 0                                 
      issuance of notes receivable to equity method investees
    		       0 -2,000,000                                     
      financing activities:
    		                                             
      proceeds from issuance of convertible notes due 2025
    		               0                              
      convertible notes due 2025 issuance costs
    		               0                              
      payments on revolving credit facility
    		               0 -275,000,000 -15,000,000 -15,000,000 -10,000,000 -45,000,000   0 0 -261,168,000 -15,000,000  -17,500,000                 
      capital contributions - non-controlling shareholders
    		            3,178,000                                 
      payments of deferred consideration on prior acquisitions
    		               0                              
      purchase of capped calls
    		                                             
      taxes paid in lieu of shares issued for stock-based compensation
    		       -2,903,000 -2,500,000 -5,543,000 -12,570,000 -3,215,000 -4,294,000 -3,479,000 -9,541,000 -3,218,000                              
      share repurchases
    		       -76,515,000 0   -1,904,000 0                                 
      finance lease payments
    		       -4,138,000 -27,000 -2,063,000 -12,454,000                                   
      effect of exchange rate changes on cash
    		       -3,036,000 -1,071,000 -1,430,000 -627,000 -11,000 -20,000 -472,000 -52,000 178,000 333,000 154,000 -1,496,000 -221,000 -344,000 54,000 112,000 455,000 -475,000 -463,000 -109,000  -113,000                 
      increase in cash, cash equivalents and restricted cash
    		       -79,157,000    35,480,000 24,275,000   21,648,000 270,674,000   10,873,000 -6,161,000   135,823,000 19,440,000                     
      supplemental disclosure of cash flow information - net cash paid during the period for income taxes
    		       4,204,000 2,456,000 4,744,000 716,000 2,025,000 2,818,000 1,198,000 1,879,000 2,955,000   814,000 293,000 1,705,000 1,123,000 4,998,000                       
      supplemental disclosure of cash flow information - cash paid during the period for interest
    		       3,195,000 2,260,000 3,337,000 2,254,000 3,338,000 2,261,000 3,333,000 2,200,000 3,338,000   2,740,000 5,717,000 1,861,000 5,736,000 216,000   2,297,000 1,974,000  927,000  1,569,000 65,000              
      supplemental disclosure of non-cash operating, investing and financing activities:
    		                                             
      contingent consideration issued in acquisition of businesses
    		               0   5,239,000 -100,000 0                         
      purchase of fixed assets included in accounts payable and accrued expenses and other liabilities
    		       2,836,000 -938,000 425,000 1,883,000 879,000 -383,000 -297,000 1,129,000 737,000   1,752,000 -430,000 695,000 1,208,000 359,000      245,000                 
      property and equipment acquired through financing leases
    		                                             
      transfer of non-controlling units
    		               0                              
      lease related impairments, including right of use assets
    		                                             
      revolving credit facility issuance costs
    		        0 -3,000 -1,869,000         0                          
      purchase liabilities included in other non-current liabilities
    		            -349,000      257,000 0 0 0 5,468,000                       
      fixed assets acquired through finance lease
    		        865,000 2,063,000 12,454,000                                   
      assets obtained in exchange for lease liabilities
    		        2,201,000    3,388,000                                 
      impairment of right of use assets
    		           0 427,000   1,235,000 0                             
      decrease in cash, cash equivalents and restricted cash
    		         -21,499,000 -69,665,000    -12,588,000    -13,986,000    -43,610,000    -15,922,000                   
      gain on acquisition of equity method investment
    		               0 0 0 -4,230,000                           
      loss allocation from equity method investments
    		           1,540,000 1,508,000 757,000 3,288,000 1,119,000 994,000 1,256,000 2,030,000                           
      gain on life insurance proceeds
    		                                             
      proceeds from life insurance policy
    		                                             
      payment of convertible notes due 2019
    		                                             
      capital contribution - non-controlling interest
    		                                             
      common stock issued in acquisition of business
    		                   0 0                         
      right of use assets in exchange for lease liabilities
    		                                             
      share repurchase
    		              -1,672,000                               
      deferred rent and lease incentive amortization
    		                       263,000 -661,000 684,000 385,000                   
      proceeds from issuance of convertible notes due 2023
    		                       0 0                     
      convertible notes due 2023 issuance costs
    		                       0 -494,000                     
      issuance of common stock and warrants - private placement, net of offering costs
    		                                             
      purchase of ers units
    		                                             
      issuance of restricted stock units
    		               1,000 0 1,000 2,000 1,000 1,000 1,000 2,000 0 1,000 1,000 2,000  0                 
      transaction costs of issuance of common stock and warrants included in accrued expenses and other liabilities
    		                                             
      accrued payment to fund deferred compensation liability included in accounts payable
    		                          1,551,000                   
      purchase of treasury stock for stock-based tax withholdings
    		                 -3,617,000 -9,199,000 -3,410,000 -3,735,000 -6,143,000 -9,819,000 -2,932,000 -3,489,000 -5,099,000 -9,296,000  -1,969,000                 
      loss allocation from equity method investment
    		                   854,000 957,000 347,000 203,000 77,000 258,000 151,000 660,000  282,000                 
      investment in private companies
    		                                             
      payments of definite consideration
    		                            0                 
      payments of purchase consideration liabilities
    		                            0                 
      payment of term notes
    		                            0                 
      non-cash debt issuance costs
    		                                             
      non-cash based compensation expense
    		                                             
      stock-based compensation expense
    		                      12,864,000 10,671,000 10,603,000 10,476,000 8,495,000  8,048,000                 
      purchase of property and equipment
    		                      -5,247,000 -3,436,000 -7,519,000 -4,581,000 -4,988,000  -2,251,000      -605,000 -740,000 -1,099,000 -2,386,000 -613,000 -541,000 -1,340,000 -1,498,000 -1,419,000 -791,000 -664,000 
      acquisition of business
    		                      -11,061,000                       
      contingent consideration issued in business acquisition
    		                      7,580,000                       
      fair market value adjustment to contingent consideration
    		                                             
      impairment of equity method investment
    		                                             
      loss on disposal of fixed assets
    		                       132,000 47,000 0 10,000  0                 
      fees and other receivables
    		                            -647,000                 
      acquisition of businesses
    		                       342,000 -6,614,000 -9,762,000 -178,583,000          0       0  
      common stock acquired under the share repurchase program
    		                                             
      contingent consideration issued in business acquisitions
    		                                             
      supplemental disclosure of cash flow information - net cash paid (refunded) during the period for income taxes
    		                          1,359,000                   
      purchase of fixed assets included in accrued expenses and other liabilities
    		                          1,331,000                   
      effect of exchange rate on changes on cash
    		                                             
      net increase in cash and cash equivalents
    		                                             
      fair market value adjustment on contingent consideration
    		                                             
      investment in private company
    		                                             
      acquisition of businesses, net of cash acquired
    		                                             
      debt issuance costs
    		                                             
      decrease in cash and cash equivalents
    		                            20,974,000                 
      supplemental disclosure of cash flow information - net cash refunded (paid) during the period for income taxes
    		                            1,174,000                 
      contingent consideration issued in a business acquisition
    		                                             
      deferred rent and lease incentive
    		                              51,000 168,000 -950,000  20,000 23,000 4,000 1,373,000 -11,000  467,000 -41,000 -69,000   
      excess tax benefits from stock-based compensation expense
    		                              4,027,000 11,468,000 1,883,000             
      accretion on contingent consideration
    		                              309,000 342,000              
      payment on revolving credit facility
    		                                             
      issuance of redeemable units in ers
    		                                             
      purchase of treasury stock for stock-based minimum tax withholdings
    		                                             
      stock and stock options issued in acquisition of business
    		                                             
      purchase liabilities included in accrued expenses
    		                                             
      purchase of fixed assets included in accounts payable
    		                                             
      tax shortfall (excess tax benefit) from stock-based compensation expense
    		                                             
      excess tax benefit (shortfall) from stock-based compensation expense
    		                                             
      increase in cash and cash equivalents
    		                               160,000 41,435,000 13,259,000 2,235,000 8,850,000 7,733,000 -57,236,000 5,727,000 -18,644,000 4,953,000 6,785,000 4,147,000 4,103,000  
      purchase consideration liabilities included in accrued expenses and other liabilities
    		                                             
      impairment of long-lived assets
    		                                             
      excess tax benefits from stock-based compensation
    		                                  -160,000           
      interest expense
    		                              2,341,000 2,356,000     0 0 3,000  206,000 204,000 211,000 243,000 193,000 
      proceeds from issuance of convertible notes
    		                                             
      convertible notes issuance costs
    		                                             
      proceeds from issuance of term notes
    		                                             
      payment of promissory note
    		                                             
      proceeds from exercise of warrants
    		                                 0          0 20,000 
      supplemental disclosure of cash flow information - cash paid during the period for income taxes, net of refunds
    		                              316,000 475,000 136,000  416,000           
      common stock issued in business acquisitions
    		                                             
      attribution of the fair market value of replacement awards
    		                                             
      issuance of promissory note for acquisition
    		                                             
      settlement of contingent consideration liability upon issuance of ers, llc membership interest
    		                                0             
      stock-based compensation
    		                              3,330,000 3,419,000  2,457,000 2,306,000 1,217,000 1,195,000 1,135,000 795,000 703,000 714,000 829,000 816,000 623,000 584,000 
      accrued expenses
    		                                 4,443,000 260,000 1,309,000 2,407,000 1,117,000 -1,733,000 361,000 322,000 1,331,000 -1,212,000 1,286,000  
      issuance of restricted stock
    		                              0 2,000  0  0 0         
      acquisition of business, net of cash acquired
    		                                             
      acquired purchase option
    		                                             
      imputed interest expense
    		                                284,000             
      proceeds from bank indebtedness
    		                                             
      payment of contingent consideration
    		                                             
      issuance of ers, llc redeemable units
    		                                             
      contingent consideration liability issued in acquisition of business
    		                                             
      amortization of customer inducements
    		                                       948,000 1,207,000 1,207,000 1,206,000 1,307,000 1,146,000 
      loss on investments
    		                                             
      impairment of customer inducement asset
    		                                             
      contract settlement charges
    		                                             
      customer inducements
    		                                       0 0   0  
      repayment of notes payable assumed in acquisition
    		                                   0 0         
      purchase of treasury stock
    		                                  -367,000 -15,000 -44,000 0 -78,000 0 0 0 -94,000 -762,000 -1,216,000 
      supplemental disclosure of non-cash investing and financing activities:
    		                                             
      non-cash consideration issued in a business acquisition
    		                                             
      supplemental disclosure of cash flow information:
    		                                             
      cash paid during the period for income taxes, net of refunds
    		                                             
      contigent consideration liability issued in acquisition of business
    		                                             
      issuance of common stock - vesting of restricted stock
    		                                  1,000           
      gain on investments
    		                                             
      proceeds from repayment of notes receivable
    		                                           0 857,000 
      increase in notes receivable
    		                                           0 -8,000 
      proceeds from investments
    		                                   3,000 1,000 6,000 -3,000 5,000 6,000 2,000 15,000 4,000 5,000 
      net proceeds from issuance of common stock
    		                                           0  
      preferred stock dividends
    		                                           0  
      supplemental disclosure of cash flow information – cash paid during the period for income taxes, net of refunds
    		                                             
      issuance of warrant for customer inducement
    		                                           0 0 
      customer inducement payable
    		                                           1,693,000  
      note payable assumed in a business acquisition
    		                                           0 0 
      goodwill - working capital settlement
    		                                    0         
      supplemental disclosure of cash flow information - cash paid during the period for:
    		                                             
      income taxes
    		                                    279,000 -16,000 341,000 81,000 341,000 282,000 109,000 65,000 49,000 
      goodwill adjustment
    		                                      889,000       
      amortization of deferred rent and lease incentive
    		                                           -70,000 -68,000 
      impairment of investments
    		                                             
      write-off of customer inducement asset
    		                                             
      changes in operating assets and liabilities, net of effect of acquisitions:
    		                                             
      repayment of notes payable
    		                                       0 0     
      investments in non-marketable securities
    		                                             
      supplemental disclosure of cash flow information – cash paid during the period for:
    		                                             
      purchase of non-marketable securities
    		                                             
      exercise of redemption rights into note receivable
    		                                             
      unrealized (gain) loss on investments
    		                                             
      proceeds from issuance of preferred stock
    		                                             
      net proceed from issuance of common stock
    		                                             
      unrealized gain on investments
    		                                         -1,000 -3,000   
      net cash (used in) investing activities
    		                                           -1,165,000 -749,000 
      net proceeds from issuance of preferred stock
    		                                             
      contingent consideration issued in a business combination
    		                                             
      unrealized (gain) on investments
    		                                             
      increase in fees receivable
    		                                             
      increase in prepaid expenses and other current assets
    		                                             
      increase in other non-current assets
    		                                             
      increase in customer inducements
    		                                             
      increase in accrued expenses
    		                                             
      increase in accounts payable
    		                                             
      increase in deferred revenue
    		                                             
      increase in other non-current liabilities
    		                                             
      customer inducement - other
    		                                             
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.